nodes	percent_of_prediction	percent_of_DWPC	metapath
Remifentanil—Hyperglycaemia—Dexamethasone—psoriatic arthritis	0.00358	0.00358	CcSEcCtD
Remifentanil—Bradycardia—Triamcinolone—psoriatic arthritis	0.00357	0.00357	CcSEcCtD
Remifentanil—Bradycardia—Methylprednisolone—psoriatic arthritis	0.00356	0.00356	CcSEcCtD
Remifentanil—Visual disturbance—Methotrexate—psoriatic arthritis	0.00353	0.00353	CcSEcCtD
Remifentanil—Haemoglobin—Triamcinolone—psoriatic arthritis	0.00352	0.00352	CcSEcCtD
Remifentanil—Haemoglobin—Methylprednisolone—psoriatic arthritis	0.00351	0.00351	CcSEcCtD
Remifentanil—Haemorrhage—Triamcinolone—psoriatic arthritis	0.0035	0.0035	CcSEcCtD
Remifentanil—Haemorrhage—Methylprednisolone—psoriatic arthritis	0.0035	0.0035	CcSEcCtD
Remifentanil—Hallucination—Methylprednisolone—psoriatic arthritis	0.00348	0.00348	CcSEcCtD
Remifentanil—Pharyngitis—Triamcinolone—psoriatic arthritis	0.00348	0.00348	CcSEcCtD
Remifentanil—Arrhythmia—Prednisolone—psoriatic arthritis	0.0034	0.0034	CcSEcCtD
Remifentanil—Visual impairment—Methylprednisolone—psoriatic arthritis	0.00337	0.00337	CcSEcCtD
Remifentanil—Erythema—Prednisolone—psoriatic arthritis	0.00332	0.00332	CcSEcCtD
Remifentanil—Cardiac disorder—Methylprednisolone—psoriatic arthritis	0.00324	0.00324	CcSEcCtD
Remifentanil—Bradycardia—Dexamethasone—psoriatic arthritis	0.00324	0.00324	CcSEcCtD
Remifentanil—Bradycardia—Betamethasone—psoriatic arthritis	0.00324	0.00324	CcSEcCtD
Remifentanil—Haemoglobin—Dexamethasone—psoriatic arthritis	0.00319	0.00319	CcSEcCtD
Remifentanil—Haemoglobin—Betamethasone—psoriatic arthritis	0.00319	0.00319	CcSEcCtD
Remifentanil—Haemorrhage—Dexamethasone—psoriatic arthritis	0.00318	0.00318	CcSEcCtD
Remifentanil—Haemorrhage—Betamethasone—psoriatic arthritis	0.00318	0.00318	CcSEcCtD
Remifentanil—Angiopathy—Methylprednisolone—psoriatic arthritis	0.00317	0.00317	CcSEcCtD
Remifentanil—Hallucination—Dexamethasone—psoriatic arthritis	0.00316	0.00316	CcSEcCtD
Remifentanil—Hallucination—Betamethasone—psoriatic arthritis	0.00316	0.00316	CcSEcCtD
Remifentanil—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.00316	0.00316	CcSEcCtD
Remifentanil—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.00315	0.00315	CcSEcCtD
Remifentanil—Arrhythmia—Triamcinolone—psoriatic arthritis	0.00313	0.00313	CcSEcCtD
Remifentanil—Arrhythmia—Methylprednisolone—psoriatic arthritis	0.00312	0.00312	CcSEcCtD
Remifentanil—Hyperglycaemia—Prednisone—psoriatic arthritis	0.00312	0.00312	CcSEcCtD
Remifentanil—Visual impairment—Dexamethasone—psoriatic arthritis	0.00306	0.00306	CcSEcCtD
Remifentanil—Visual impairment—Betamethasone—psoriatic arthritis	0.00306	0.00306	CcSEcCtD
Remifentanil—Erythema—Triamcinolone—psoriatic arthritis	0.00305	0.00305	CcSEcCtD
Remifentanil—Erythema—Methylprednisolone—psoriatic arthritis	0.00304	0.00304	CcSEcCtD
Remifentanil—Syncope—Prednisolone—psoriatic arthritis	0.00297	0.00297	CcSEcCtD
Remifentanil—Loss of consciousness—Prednisolone—psoriatic arthritis	0.00291	0.00291	CcSEcCtD
Remifentanil—Angiopathy—Dexamethasone—psoriatic arthritis	0.00288	0.00288	CcSEcCtD
Remifentanil—Angiopathy—Betamethasone—psoriatic arthritis	0.00288	0.00288	CcSEcCtD
Remifentanil—Convulsion—Prednisolone—psoriatic arthritis	0.00287	0.00287	CcSEcCtD
Remifentanil—Hypertension—Prednisolone—psoriatic arthritis	0.00286	0.00286	CcSEcCtD
Remifentanil—Arrhythmia—Betamethasone—psoriatic arthritis	0.00284	0.00284	CcSEcCtD
Remifentanil—Arrhythmia—Dexamethasone—psoriatic arthritis	0.00284	0.00284	CcSEcCtD
Remifentanil—Bradycardia—Prednisone—psoriatic arthritis	0.00282	0.00282	CcSEcCtD
Remifentanil—Haemoglobin—Prednisone—psoriatic arthritis	0.00278	0.00278	CcSEcCtD
Remifentanil—Abdominal discomfort—Methotrexate—psoriatic arthritis	0.00277	0.00277	CcSEcCtD
Remifentanil—Haemorrhage—Prednisone—psoriatic arthritis	0.00277	0.00277	CcSEcCtD
Remifentanil—Erythema—Betamethasone—psoriatic arthritis	0.00277	0.00277	CcSEcCtD
Remifentanil—Erythema—Dexamethasone—psoriatic arthritis	0.00277	0.00277	CcSEcCtD
Remifentanil—Hallucination—Prednisone—psoriatic arthritis	0.00275	0.00275	CcSEcCtD
Remifentanil—Syncope—Triamcinolone—psoriatic arthritis	0.00273	0.00273	CcSEcCtD
Remifentanil—Syncope—Methylprednisolone—psoriatic arthritis	0.00273	0.00273	CcSEcCtD
Remifentanil—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.00271	0.00271	CcSEcCtD
Remifentanil—Oedema—Prednisolone—psoriatic arthritis	0.00271	0.00271	CcSEcCtD
Remifentanil—Dysuria—Methotrexate—psoriatic arthritis	0.0027	0.0027	CcSEcCtD
Remifentanil—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.00268	0.00268	CcSEcCtD
Remifentanil—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.00267	0.00267	CcSEcCtD
Remifentanil—Shock—Prednisolone—psoriatic arthritis	0.00266	0.00266	CcSEcCtD
Remifentanil—Cough—Triamcinolone—psoriatic arthritis	0.00266	0.00266	CcSEcCtD
Remifentanil—Convulsion—Triamcinolone—psoriatic arthritis	0.00264	0.00264	CcSEcCtD
Remifentanil—Tachycardia—Prednisolone—psoriatic arthritis	0.00264	0.00264	CcSEcCtD
Remifentanil—Convulsion—Methylprednisolone—psoriatic arthritis	0.00264	0.00264	CcSEcCtD
Remifentanil—Hypertension—Triamcinolone—psoriatic arthritis	0.00263	0.00263	CcSEcCtD
Remifentanil—Hypertension—Methylprednisolone—psoriatic arthritis	0.00263	0.00263	CcSEcCtD
Remifentanil—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00262	0.00262	CcSEcCtD
Remifentanil—Pneumonia—Methotrexate—psoriatic arthritis	0.00259	0.00259	CcSEcCtD
Remifentanil—Anxiety—Methylprednisolone—psoriatic arthritis	0.00258	0.00258	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00257	0.00257	CcSEcCtD
Remifentanil—Flushing—Prednisone—psoriatic arthritis	0.00257	0.00257	CcSEcCtD
Remifentanil—Dry mouth—Triamcinolone—psoriatic arthritis	0.00254	0.00254	CcSEcCtD
Remifentanil—Renal failure—Methotrexate—psoriatic arthritis	0.00253	0.00253	CcSEcCtD
Remifentanil—Angiopathy—Prednisone—psoriatic arthritis	0.00251	0.00251	CcSEcCtD
Remifentanil—Confusional state—Methylprednisolone—psoriatic arthritis	0.0025	0.0025	CcSEcCtD
Remifentanil—Immune system disorder—Prednisone—psoriatic arthritis	0.0025	0.0025	CcSEcCtD
Remifentanil—Oedema—Triamcinolone—psoriatic arthritis	0.00249	0.00249	CcSEcCtD
Remifentanil—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00249	0.00249	CcSEcCtD
Remifentanil—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00248	0.00248	CcSEcCtD
Remifentanil—Syncope—Betamethasone—psoriatic arthritis	0.00248	0.00248	CcSEcCtD
Remifentanil—Syncope—Dexamethasone—psoriatic arthritis	0.00248	0.00248	CcSEcCtD
Remifentanil—Arrhythmia—Prednisone—psoriatic arthritis	0.00247	0.00247	CcSEcCtD
Remifentanil—Sweating—Methotrexate—psoriatic arthritis	0.00247	0.00247	CcSEcCtD
Remifentanil—Haematuria—Methotrexate—psoriatic arthritis	0.00246	0.00246	CcSEcCtD
Remifentanil—Shock—Triamcinolone—psoriatic arthritis	0.00245	0.00245	CcSEcCtD
Remifentanil—Shock—Methylprednisolone—psoriatic arthritis	0.00244	0.00244	CcSEcCtD
Remifentanil—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00244	0.00244	CcSEcCtD
Remifentanil—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00243	0.00243	CcSEcCtD
Remifentanil—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00243	0.00243	CcSEcCtD
Remifentanil—Paraesthesia—Prednisolone—psoriatic arthritis	0.00243	0.00243	CcSEcCtD
Remifentanil—Tachycardia—Triamcinolone—psoriatic arthritis	0.00243	0.00243	CcSEcCtD
Remifentanil—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00242	0.00242	CcSEcCtD
Remifentanil—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00241	0.00241	CcSEcCtD
Remifentanil—Erythema—Prednisone—psoriatic arthritis	0.00241	0.00241	CcSEcCtD
Remifentanil—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00241	0.00241	CcSEcCtD
Remifentanil—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.0024	0.0024	CcSEcCtD
Remifentanil—Convulsion—Betamethasone—psoriatic arthritis	0.0024	0.0024	CcSEcCtD
Remifentanil—Convulsion—Dexamethasone—psoriatic arthritis	0.0024	0.0024	CcSEcCtD
Remifentanil—Hypertension—Dexamethasone—psoriatic arthritis	0.00239	0.00239	CcSEcCtD
Remifentanil—Hypertension—Betamethasone—psoriatic arthritis	0.00239	0.00239	CcSEcCtD
Remifentanil—Anxiety—Dexamethasone—psoriatic arthritis	0.00235	0.00235	CcSEcCtD
Remifentanil—Anxiety—Betamethasone—psoriatic arthritis	0.00235	0.00235	CcSEcCtD
Remifentanil—Haemoglobin—Methotrexate—psoriatic arthritis	0.00233	0.00233	CcSEcCtD
Remifentanil—Hypotension—Methylprednisolone—psoriatic arthritis	0.00232	0.00232	CcSEcCtD
Remifentanil—Pain—Prednisolone—psoriatic arthritis	0.00231	0.00231	CcSEcCtD
Remifentanil—Haemorrhage—Methotrexate—psoriatic arthritis	0.00231	0.00231	CcSEcCtD
Remifentanil—Pharyngitis—Methotrexate—psoriatic arthritis	0.0023	0.0023	CcSEcCtD
Remifentanil—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.00226	0.00226	CcSEcCtD
Remifentanil—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.00226	0.00226	CcSEcCtD
Remifentanil—Oedema—Betamethasone—psoriatic arthritis	0.00226	0.00226	CcSEcCtD
Remifentanil—Oedema—Dexamethasone—psoriatic arthritis	0.00226	0.00226	CcSEcCtD
Remifentanil—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00223	0.00223	CcSEcCtD
Remifentanil—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00223	0.00223	CcSEcCtD
Remifentanil—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00223	0.00223	CcSEcCtD
Remifentanil—Visual impairment—Methotrexate—psoriatic arthritis	0.00223	0.00223	CcSEcCtD
Remifentanil—Anaemia—Prednisone—psoriatic arthritis	0.00223	0.00223	CcSEcCtD
Remifentanil—Shock—Betamethasone—psoriatic arthritis	0.00222	0.00222	CcSEcCtD
Remifentanil—Shock—Dexamethasone—psoriatic arthritis	0.00222	0.00222	CcSEcCtD
Remifentanil—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00222	0.00222	CcSEcCtD
Remifentanil—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00221	0.00221	CcSEcCtD
Remifentanil—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00221	0.00221	CcSEcCtD
Remifentanil—Agitation—Prednisone—psoriatic arthritis	0.00221	0.00221	CcSEcCtD
Remifentanil—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.00221	0.00221	CcSEcCtD
Remifentanil—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.00221	0.00221	CcSEcCtD
Remifentanil—Tachycardia—Dexamethasone—psoriatic arthritis	0.0022	0.0022	CcSEcCtD
Remifentanil—Tachycardia—Betamethasone—psoriatic arthritis	0.0022	0.0022	CcSEcCtD
Remifentanil—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00219	0.00219	CcSEcCtD
Remifentanil—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00219	0.00219	CcSEcCtD
Remifentanil—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00218	0.00218	CcSEcCtD
Remifentanil—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00218	0.00218	CcSEcCtD
Remifentanil—Syncope—Prednisone—psoriatic arthritis	0.00216	0.00216	CcSEcCtD
Remifentanil—Urticaria—Prednisolone—psoriatic arthritis	0.00215	0.00215	CcSEcCtD
Remifentanil—Cardiac disorder—Methotrexate—psoriatic arthritis	0.00215	0.00215	CcSEcCtD
Remifentanil—Pain—Triamcinolone—psoriatic arthritis	0.00213	0.00213	CcSEcCtD
Remifentanil—Loss of consciousness—Prednisone—psoriatic arthritis	0.00212	0.00212	CcSEcCtD
Remifentanil—Hypotension—Dexamethasone—psoriatic arthritis	0.00211	0.00211	CcSEcCtD
Remifentanil—Hypotension—Betamethasone—psoriatic arthritis	0.00211	0.00211	CcSEcCtD
Remifentanil—Angiopathy—Methotrexate—psoriatic arthritis	0.0021	0.0021	CcSEcCtD
Remifentanil—Immune system disorder—Methotrexate—psoriatic arthritis	0.00209	0.00209	CcSEcCtD
Remifentanil—Convulsion—Prednisone—psoriatic arthritis	0.00209	0.00209	CcSEcCtD
Remifentanil—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.00208	0.00208	CcSEcCtD
Remifentanil—Hypertension—Prednisone—psoriatic arthritis	0.00208	0.00208	CcSEcCtD
Remifentanil—Chills—Methotrexate—psoriatic arthritis	0.00208	0.00208	CcSEcCtD
Remifentanil—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00205	0.00205	CcSEcCtD
Remifentanil—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00205	0.00205	CcSEcCtD
Remifentanil—Anxiety—Prednisone—psoriatic arthritis	0.00204	0.00204	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00204	0.00204	CcSEcCtD
Remifentanil—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00203	0.00203	CcSEcCtD
Remifentanil—Paraesthesia—Betamethasone—psoriatic arthritis	0.00203	0.00203	CcSEcCtD
Remifentanil—Erythema—Methotrexate—psoriatic arthritis	0.00201	0.00201	CcSEcCtD
Remifentanil—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00199	0.00199	CcSEcCtD
Remifentanil—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00199	0.00199	CcSEcCtD
Remifentanil—Dyspepsia—Betamethasone—psoriatic arthritis	0.00199	0.00199	CcSEcCtD
Remifentanil—Urticaria—Triamcinolone—psoriatic arthritis	0.00198	0.00198	CcSEcCtD
Remifentanil—Urticaria—Methylprednisolone—psoriatic arthritis	0.00197	0.00197	CcSEcCtD
Remifentanil—Body temperature increased—Triamcinolone—psoriatic arthritis	0.00197	0.00197	CcSEcCtD
Remifentanil—Anaphylactic shock—Prednisone—psoriatic arthritis	0.00197	0.00197	CcSEcCtD
Remifentanil—Oedema—Prednisone—psoriatic arthritis	0.00197	0.00197	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00195	0.00195	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00195	0.00195	CcSEcCtD
Remifentanil—Shock—Prednisone—psoriatic arthritis	0.00193	0.00193	CcSEcCtD
Remifentanil—Pain—Betamethasone—psoriatic arthritis	0.00193	0.00193	CcSEcCtD
Remifentanil—Pain—Dexamethasone—psoriatic arthritis	0.00193	0.00193	CcSEcCtD
Remifentanil—Nervous system disorder—Prednisone—psoriatic arthritis	0.00193	0.00193	CcSEcCtD
Remifentanil—Tachycardia—Prednisone—psoriatic arthritis	0.00192	0.00192	CcSEcCtD
Remifentanil—Skin disorder—Prednisone—psoriatic arthritis	0.00191	0.00191	CcSEcCtD
Remifentanil—Hyperhidrosis—Prednisone—psoriatic arthritis	0.0019	0.0019	CcSEcCtD
Remifentanil—Anaemia—Methotrexate—psoriatic arthritis	0.00186	0.00186	CcSEcCtD
Remifentanil—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00186	0.00186	CcSEcCtD
Remifentanil—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00186	0.00186	CcSEcCtD
Remifentanil—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00183	0.00183	CcSEcCtD
Remifentanil—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00183	0.00183	CcSEcCtD
Remifentanil—Urticaria—Dexamethasone—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Remifentanil—Urticaria—Betamethasone—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Remifentanil—Dizziness—Prednisolone—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Remifentanil—Body temperature increased—Betamethasone—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Remifentanil—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Remifentanil—Paraesthesia—Prednisone—psoriatic arthritis	0.00177	0.00177	CcSEcCtD
Remifentanil—Pruritus—Triamcinolone—psoriatic arthritis	0.00176	0.00176	CcSEcCtD
Remifentanil—Cough—Methotrexate—psoriatic arthritis	0.00176	0.00176	CcSEcCtD
Remifentanil—Pruritus—Methylprednisolone—psoriatic arthritis	0.00176	0.00176	CcSEcCtD
Remifentanil—Convulsion—Methotrexate—psoriatic arthritis	0.00174	0.00174	CcSEcCtD
Remifentanil—Dyspepsia—Prednisone—psoriatic arthritis	0.00173	0.00173	CcSEcCtD
Remifentanil—Rash—Prednisolone—psoriatic arthritis	0.00171	0.00171	CcSEcCtD
Remifentanil—Dermatitis—Prednisolone—psoriatic arthritis	0.0017	0.0017	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.0017	0.0017	CcSEcCtD
Remifentanil—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.0017	0.0017	CcSEcCtD
Remifentanil—Headache—Prednisolone—psoriatic arthritis	0.0017	0.0017	CcSEcCtD
Remifentanil—Constipation—Prednisone—psoriatic arthritis	0.00168	0.00168	CcSEcCtD
Remifentanil—Confusional state—Methotrexate—psoriatic arthritis	0.00166	0.00166	CcSEcCtD
Remifentanil—Dizziness—Triamcinolone—psoriatic arthritis	0.00165	0.00165	CcSEcCtD
Remifentanil—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Remifentanil—Dizziness—Methylprednisolone—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Remifentanil—Feeling abnormal—Prednisone—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Remifentanil—Nervous system disorder—Methotrexate—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Remifentanil—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Remifentanil—Nausea—Prednisolone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Remifentanil—Pruritus—Dexamethasone—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Remifentanil—Pruritus—Betamethasone—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Remifentanil—Skin disorder—Methotrexate—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Remifentanil—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Remifentanil—Vomiting—Triamcinolone—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Remifentanil—Vomiting—Methylprednisolone—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Remifentanil—Rash—Triamcinolone—psoriatic arthritis	0.00157	0.00157	CcSEcCtD
Remifentanil—Dermatitis—Triamcinolone—psoriatic arthritis	0.00157	0.00157	CcSEcCtD
Remifentanil—Rash—Methylprednisolone—psoriatic arthritis	0.00157	0.00157	CcSEcCtD
Remifentanil—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Remifentanil—Urticaria—Prednisone—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Remifentanil—Headache—Triamcinolone—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Remifentanil—Headache—Methylprednisolone—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Remifentanil—Body temperature increased—Prednisone—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Remifentanil—Diarrhoea—Dexamethasone—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Remifentanil—Diarrhoea—Betamethasone—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Remifentanil—Hypotension—Methotrexate—psoriatic arthritis	0.00154	0.00154	CcSEcCtD
Remifentanil—Dizziness—Betamethasone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Remifentanil—Dizziness—Dexamethasone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Remifentanil—Nausea—Triamcinolone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Remifentanil—Paraesthesia—Methotrexate—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Remifentanil—Nausea—Methylprednisolone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Remifentanil—Dyspnoea—Methotrexate—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Remifentanil—Somnolence—Methotrexate—psoriatic arthritis	0.00146	0.00146	CcSEcCtD
Remifentanil—Hypersensitivity—Prednisone—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Remifentanil—Dyspepsia—Methotrexate—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Remifentanil—Vomiting—Betamethasone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Remifentanil—Vomiting—Dexamethasone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Remifentanil—Rash—Dexamethasone—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Remifentanil—Rash—Betamethasone—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Remifentanil—Dermatitis—Betamethasone—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Remifentanil—Dermatitis—Dexamethasone—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Remifentanil—Headache—Betamethasone—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Remifentanil—Headache—Dexamethasone—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Remifentanil—Pain—Methotrexate—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Remifentanil—Pruritus—Prednisone—psoriatic arthritis	0.00139	0.00139	CcSEcCtD
Remifentanil—Feeling abnormal—Methotrexate—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Remifentanil—Diarrhoea—Prednisone—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Remifentanil—Nausea—Dexamethasone—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Remifentanil—Nausea—Betamethasone—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Remifentanil—Urticaria—Methotrexate—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Remifentanil—Dizziness—Prednisone—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Remifentanil—Body temperature increased—Methotrexate—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Remifentanil—Vomiting—Prednisone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Remifentanil—Rash—Prednisone—psoriatic arthritis	0.00124	0.00124	CcSEcCtD
Remifentanil—Dermatitis—Prednisone—psoriatic arthritis	0.00124	0.00124	CcSEcCtD
Remifentanil—Headache—Prednisone—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Remifentanil—Hypersensitivity—Methotrexate—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Remifentanil—Nausea—Prednisone—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Remifentanil—Pruritus—Methotrexate—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Remifentanil—Diarrhoea—Methotrexate—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Remifentanil—Dizziness—Methotrexate—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Remifentanil—Vomiting—Methotrexate—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Remifentanil—Rash—Methotrexate—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Remifentanil—Dermatitis—Methotrexate—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Remifentanil—Headache—Methotrexate—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Remifentanil—Nausea—Methotrexate—psoriatic arthritis	0.000976	0.000976	CcSEcCtD
